Pharmacology advances in the neuroscience intensive care unit.

Chris Stewart-Amidei

doi:10.1016/S0899-5885(03)00035-2

Pharmacology advances in the neuroscience intensive care unit.

Chris Stewart-Amidei^*

^*Corresponding author for this work

Neurological Surgery

Research output: Contribution to journal › Article › peer-review

Abstract

New drugs are continuously being developed to enhance care in the neuro ICU. Newer drugs with special implications for the neurologically impaired population include fosphenytoin, tissue plasminogen activator, and propofol. Nurses are challenged to use these drugs in a safe and effective manner.

Original language	English (US)
Pages (from-to)	31-38
Number of pages	8
Journal	Critical Care Nursing Clinics of North America
Volume	14
Issue number	1
DOIs	https://doi.org/10.1016/S0899-5885(03)00035-2
State	Published - Jan 1 2002

ASJC Scopus subject areas

Critical Care

Access to Document

10.1016/S0899-5885(03)00035-2

Fingerprint Dive into the research topics of 'Pharmacology advances in the neuroscience intensive care unit.'. Together they form a unique fingerprint.

Cite this

@article{51d5c08758d2434b857104fe79c6a48d,

title = "Pharmacology advances in the neuroscience intensive care unit.",

abstract = "New drugs are continuously being developed to enhance care in the neuro ICU. Newer drugs with special implications for the neurologically impaired population include fosphenytoin, tissue plasminogen activator, and propofol. Nurses are challenged to use these drugs in a safe and effective manner.",

author = "Chris Stewart-Amidei",

year = "2002",

month = jan,

day = "1",

doi = "10.1016/S0899-5885(03)00035-2",

language = "English (US)",

volume = "14",

pages = "31--38",

journal = "Critical Care Nursing Clinics of North America",

issn = "0899-5885",

publisher = "W.B. Saunders Ltd",

number = "1",

}

TY - JOUR

T1 - Pharmacology advances in the neuroscience intensive care unit.

AU - Stewart-Amidei, Chris

PY - 2002/1/1

Y1 - 2002/1/1

N2 - New drugs are continuously being developed to enhance care in the neuro ICU. Newer drugs with special implications for the neurologically impaired population include fosphenytoin, tissue plasminogen activator, and propofol. Nurses are challenged to use these drugs in a safe and effective manner.

AB - New drugs are continuously being developed to enhance care in the neuro ICU. Newer drugs with special implications for the neurologically impaired population include fosphenytoin, tissue plasminogen activator, and propofol. Nurses are challenged to use these drugs in a safe and effective manner.

UR - http://www.scopus.com/inward/record.url?scp=0036514399&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036514399&partnerID=8YFLogxK

U2 - 10.1016/S0899-5885(03)00035-2

DO - 10.1016/S0899-5885(03)00035-2

M3 - Article

C2 - 11939643

AN - SCOPUS:0036514399

VL - 14

SP - 31

EP - 38

JO - Critical Care Nursing Clinics of North America

JF - Critical Care Nursing Clinics of North America

SN - 0899-5885

IS - 1

ER -